Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.

about

Detection of Chemical Engagement of Solute Carrier Proteins by a Cellular Thermal Shift Assay An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications

P2860

Q55115534-26343B6F-2310-4F75-B63B-AD2B8593AA27 Q58790007-D1534FB7-F60D-42CD-8068-623D09664401

P2860

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.

Item

http://www.wikidata.org/entity/Q42378327

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pre-clinical pharmacology of A ...... lymphoma anti-tumor activity.

@en

Pre-clinical pharmacology of A ...... lymphoma anti-tumor activity.

@nl

type

Item

label

Pre-clinical pharmacology of A ...... lymphoma anti-tumor activity.

@en

Pre-clinical pharmacology of A ...... lymphoma anti-tumor activity.

@nl

prefLabel

Pre-clinical pharmacology of A ...... lymphoma anti-tumor activity.

@en

Pre-clinical pharmacology of A ...... lymphoma anti-tumor activity.

@nl

P1476

Pre-clinical pharmacology of A ...... lymphoma anti-tumor activity.

@en

P2093

Amanda D Benjamin

http://www.w3.org/2001/XMLSchema#string

Armelle Logie

http://www.w3.org/2001/XMLSchema#string

Clare Murray

http://www.w3.org/2001/XMLSchema#string

Filippos Michopoulos

http://www.w3.org/2001/XMLSchema#string

Haihong Zhong

http://www.w3.org/2001/XMLSchema#string

Kate F Byth

http://www.w3.org/2001/XMLSchema#string

Lorna Hopcroft

http://www.w3.org/2001/XMLSchema#string

Lorraine Mooney

http://www.w3.org/2001/XMLSchema#string

Mike A Firth

http://www.w3.org/2001/XMLSchema#string

Mitchell Revill

http://www.w3.org/2001/XMLSchema#string

P2860

The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review

The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors

Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells

Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle

AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10

Otto Warburg's contributions to current concepts of cancer metabolism

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.

P304

69219-69236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18215

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29050199

http://www.w3.org/2001/XMLSchema#string

P921

Burkitt lymphoma

Farmakologi

P932

5642474

http://www.w3.org/2001/XMLSchema#string

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.

about

P2860

P2860

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932